Works matching IS 18607179 AND DT 2017 AND VI 12 AND IP 21


Results: 10
    1
    2
    3
    4
    5

    Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.

    Published in:
    ChemMedChem, 2017, v. 12, n. 21, p. 1776, doi. 10.1002/cmdc.201700447
    By:
    • Lücking, Ulrich;
    • Scholz, Arne;
    • Lienau, Philip;
    • Siemeister, Gerhard;
    • Kosemund, Dirk;
    • Bohlmann, Rolf;
    • Briem, Hans;
    • Terebesi, Ildiko;
    • Meyer, Kirstin;
    • Prelle, Katja;
    • Denner, Karsten;
    • Bömer, Ulf;
    • Schäfer, Martina;
    • Eis, Knut;
    • Valencia, Ray;
    • Ince, Stuart;
    • von Nussbaum, Franz;
    • Mumberg, Dominik;
    • Ziegelbauer, Karl;
    • Klebl, Bert
    Publication type:
    Article
    6
    7
    8
    9
    10